Nader Khedr

As Interim Head of Fertility for the U.S., Nader leads the team responsible for our portfolio of Fertility products.

He has more than 25 years of experience in the pharmaceutical industry across global strategic and operations leadership, orchestrating complex commercial transformations across a range of therapeutic areas.

Nader joined Merck KGaA, Darmstadt, Germany in 2002 and has held leadership roles across Neurology & Immunology (N&I), Fertility & Endocrinology, and Rare Metabolic Diseases. As Head of Global Commercial Operations for the N&I franchise, he advanced strategic development and operational excellence, notably driving key initiatives for MAVENCLAD through cross-functional collaboration. With over 15 years in Fertility leadership, Nader has guided successful product launches and shaped innovative, growth-oriented strategies that consistently deliver strong results.

Nader holds a B.Sc. Pharm in Pharmaceutical Sciences from Alexandria University.